Ligand Pharmaceuticals Inc (LGND): Shares Outstanding
19.77M
As of 2025-12-31
19.92M
As of 2026-06-30
+5.3%
3-year compound annual growth
+4.2%
5-year compound annual growth
-0.1%
10-year compound annual growth
| Period ended | Shares Outstanding | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 19.77M | +3.5% | 2026-02-27, Balance as of period end |
| 2024-12-31 | 19.11M | +8.8% | 2026-02-27, Balance as of period end |
| 2023-12-31 | 17.56M | +3.6% | 2025-02-28, Balance as of period end |
| 2022-12-31 | 16.95M | +1.1% | 2024-02-29, Balance as of period end |
| 2021-12-31 | 16.77M | +4.3% | 2023-02-28, Balance as of period end |
| 2020-12-31 | 16.08M | -4.4% | 2022-02-28, Balance as of period end |
| 2019-12-31 | 16.82M | -19.0% | 2021-02-24, Balance as of period end |
| 2018-12-31 | 20.77M | -1.8% | 2020-02-27, Balance as of period end |
| 2017-12-31 | 21.15M | +1.1% | 2019-02-28, Balance as of period end |
| 2016-12-31 | 20.91M | +4.8% | 2018-03-01, Balance as of period end |
| 2015-12-31 | 19.95M | +1.9% | 2017-02-28, Balance as of period end |
| 2014-12-31 | 19.58M | -4.4% | 2016-11-14, Balance as of period end |
| 2013-12-31 | 20.47M | -3.8% | 2015-02-23, Balance as of period end |
| 2012-12-31 | 21.28M | +2.9% | 2014-12-12, Balance as of period end |
| 2011-12-31 | 20.68M | n/a | 2013-03-14, Balance as of period end |